<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1008820.ref082">
 <label>82</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Liu</surname>
   <given-names>E</given-names>
  </name>, 
  <name>
   <surname>Marin</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Banerjee</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Macapinlac</surname>
   <given-names>HA</given-names>
  </name>, 
  <name>
   <surname>Thompson</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Basar</surname>
   <given-names>R</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors</article-title>. 
  <source>N Engl J Med</source>. 
  <year>2020</year>;
  <volume>382</volume>(
  <issue>6</issue>):
  <fpage>545</fpage>â€“
  <lpage>53</lpage>. Epub 2020/02/06. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1910607</pub-id>
  <?supplied-pmid 32023374?>
  <pub-id pub-id-type="pmid">32023374</pub-id>
 </mixed-citation>
</ref>
